Clinigen Group PLC (LON:CLIN)’s share price hit a new 52-week high on Monday . The stock traded as high as GBX 1,175 ($15.51) and last traded at GBX 1,167 ($15.40), with a volume of 585,967 shares changing hands. The stock had previously closed at GBX 1,126 ($14.86).

CLIN has been the topic of several research reports. Peel Hunt reiterated an “add” rating and set a GBX 1,200 ($15.84) price objective on shares of Clinigen Group PLC in a report on Thursday, September 28th. Numis Securities Ltd lowered shares of Clinigen Group PLC to an “add” rating and set a GBX 1,100 ($14.52) target price on the stock. in a report on Tuesday, July 18th. Finally, Berenberg Bank started coverage on shares of Clinigen Group PLC in a report on Wednesday. They issued a “hold” rating and a GBX 1,200 ($15.84) target price on the stock. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of GBX 1,103 ($14.56).

The firm’s market cap is GBX 1.35 billion. The firm has a 50 day moving average price of GBX 1,108.97 and a 200-day moving average price of GBX 978.53.

Clinigen Group PLC (LON:CLIN) last issued its quarterly earnings results on Thursday, September 28th. The company reported GBX 41.80 ($0.55) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of GBX 41.20 ($0.54) by GBX 0.60 ($0.01). Clinigen Group PLC had a net margin of 0.70% and a return on equity of 0.98%. The company had revenue of £302.30 million during the quarter.

The firm also recently declared a dividend, which will be paid on Friday, December 1st. Investors of record on Thursday, November 9th will be given a dividend of GBX 3.40 ($0.04) per share. This is a boost from Clinigen Group PLC’s previous dividend of $1.60. This represents a yield of 0.32%. The ex-dividend date of this dividend is Thursday, November 9th.

In related news, insider Shaun Edward Chilton sold 100,000 shares of Clinigen Group PLC stock in a transaction dated Friday, October 13th. The shares were sold at an average price of GBX 1,150 ($15.18), for a total transaction of £1,150,000 ($1,517,550.80). Also, insider John Bacon sold 250,000 shares of Clinigen Group PLC stock in a transaction dated Monday, October 2nd. The shares were sold at an average price of GBX 1,093 ($14.42), for a total transaction of £2,732,500 ($3,605,832.67).

ILLEGAL ACTIVITY NOTICE: “Clinigen Group PLC (CLIN) Sets New 1-Year High at $1,175.00” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/11/01/clinigen-group-plc-clin-sets-new-1-year-high-at-1175-00.html.

Clinigen Group PLC Company Profile

Receive News & Stock Ratings for Clinigen Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group PLC and related stocks with our FREE daily email newsletter.